Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Gilead Sciences
Pharma
GSK allows generic versions of cabotegravir for HIV treatment
GSK has expanded its agreement with the Medicines Patent Pool, allowing generic production of cabotegravir as an HIV treatment in poorer nations.
Kevin Dunleavy
Jul 15, 2025 2:16pm
Fierce Biotech
China biotechs ‘reshaping’ US biopharma: Jefferies report
Jul 14, 2025 2:30pm
Leo ponies up €90 million for Boehringer Ingelheim's Spevigo
Jul 14, 2025 8:25am
Gilead enlists Global Fund in access campaign for new PrEP med
Jul 9, 2025 4:42pm
SCOTUS ruling enables smooth Yeztugo launch: analyst
Jul 1, 2025 9:24am
FDA removes barrier to CAR-Ts; move likely to boost uptake
Jun 27, 2025 11:14am